SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875320-23-000015
Filing Date
2023-05-18
Accepted
2023-05-18 08:56:59
Documents
12
Period of Report
2023-05-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K vrtx-20230517.htm   iXBRL 8-K 51198
  Complete submission text file 0000875320-23-000015.txt   188200

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20230517.xsd EX-101.SCH 1987
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20230517_lab.xml EX-101.LAB 24137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20230517_pre.xml EX-101.PRE 12593
6 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20230517_htm.xml XML 10656
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 23933808
SIC: 2834 Pharmaceutical Preparations